Form D · Other Investment Fund
Special Situations Life Sciences Fund LP
New York, NY · CIK 0001333549
Offering snapshot reported Jul 22, 2025 · SEC filing
- Reported sold
- $75.3M Indefinite offering
- Investors reported
- 112 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 1, 2005 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$75,037,784 → $75,337,834
- Reported investors111 → 112
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 22, 2025 | Amendment | $75,337,834 | $300,050vs Jul 22, 2024 | 112 | SEC filing |
| Jul 22, 2024 | Amendment | $75,037,784 | $0vs Jul 20, 2023 | 111 | SEC filing |
| Jul 20, 2023 | Amendment | $75,037,784 | $112,000vs Jul 16, 2021 | 111 | SEC filing |
| Jul 16, 2021 | Amendment | $74,925,784 | No comparison | Not reported | SEC filing |
| Jul 16, 2020 | Amendment | $74,925,784 | $7,718,638vs Jul 15, 2016 | 111 | SEC filing |
| Jul 16, 2019 | Amendment | $72,842,146 | $5,635,000vs Jul 15, 2016 | 110 | SEC filing |
| Jul 16, 2018 | Amendment | $71,842,146 | $4,635,000vs Jul 15, 2016 | 110 | SEC filing |
| Jul 14, 2017 | Amendment | $70,842,146 | $3,635,000vs Jul 15, 2016 | 110 | SEC filing |
| Jul 15, 2016 | Amendment | $67,207,146 | $6,492,421vs Jan 21, 2015 | 107 | SEC filing |
| Jan 21, 2015 | Amendment | $60,714,725 | No comparison | 105 | SEC filing |
| Jan 22, 2014 | Amendment | $60,064,725 | No comparison | 101 | SEC filing |
| Feb 8, 2013 | Amendment | $53,771,513 | No comparison | 89 | SEC filing |
| Jul 18, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-79282
The Issuer may from time to time elect to engage third party broker dealers. Any commissions and/or expenses paid to such broker dealers will be paid by the General Partner out of net profits.
Source: Form D, filed Jul 22, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
SPECIAL SITUATIONS LIFE SCIENCES FUND, L.P.
Investment adviser: AWM INVESTMENT COMPANY INC
- Gross asset value
- $125M
- Beneficial owners
- 45
- ADV minimum commitment
- $250K
Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- Yes
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- No
ANCHIN, BLOCK AND ANCHIN
PCAOB 168
MORGAN STANLEY & CO. LLC
SEC 8-15869
MORGAN STANLEY & CO. LLC
CRD 8209 · SEC 8-15869
Filing source
Form ADV 2082851 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-4892589007
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Awm Investment Company Inc. | Executive |
| David M. Greenhouse | Executive |
| N/A Ls Advisers, Llc | Executive |
| Ls Advisers, Llc | Executive |
| Austin W. Marxe | Executive |
| Adam Stettner | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:New York, NY, 10022